# Geneoscopy, Inc. – FDA Inspection, May 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/geneoscopy-inc/a416b54d-d22f-4a2b-8b64-85d4419b7431
Source feed: FDA_Inspections

> FDA inspection 1205472 of Geneoscopy, Inc., May 17, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 820. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1205472
- Company Name: Geneoscopy, Inc.
- Inspection Date: 2023-05-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Compliance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 2

## Related Documents

- [FDA Inspection 1269637 - 2025-05-14](https://www.keypedia.com/records/fda_inspections/geneoscopy-inc/ba091f78-89c1-4a59-ba77-bc2702212d4a)
- FDA Inspection 1208391 - 2023-04-27

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/edward-e-lockwood/3260b39e-9211-489f-8247-0ec3353e57ca)

Company: https://www.keypedia.com/companies/geneoscopy-inc/b70bf3df-90bb-48eb-8f65-c2cb50441be4

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7